Live Breaking News & Updates on Stockholder Equity
Stay updated with breaking news from Stockholder equity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024.
Exceeded Revenue and Adjusted EBITDA Guidance for Q1 2024. Improved Business Momentum in Q1 2024. Record Low Quarterly Cash Consumption in Q1 2024. . ....
06.06.2024 - Exceeded Revenue and Adjusted EBITDA Guidance for Q1 2024. Improved Business Momentum in Q1 2024. Record Low Quarterly Cash Consumption in Q1 2024. Reiterates Expectation for Revenue Growth and Free Cash Flow Breakeven in FY 2024. NEW YORK, . ....